Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusiness

NMDC s Bailadila mines production up 5% at 1.86 MT in June

The Kirandul unit of Bailadila Projects sold 8.47 lakh tonnes of iron ore in June, up 24 per cent over the same month last year.

August 31, 2020 / 04:36 PM IST
X

The Bailadila iron ore mining projects of NMDC Limited at Chhattisgarh recorded a five per cent increase in production in June this year at 18.61 lakh tonnes, compared to 17.72 lakh tonnes in the same period last year, despite lockdown, the company said on Wednesday.

The Kirandul unit of Bailadila Projects sold 8.47 lakh tonnes of iron ore in June, up 24 per cent over the same month last year.

"This is a wonderful achievement in increasing production and sales by the personnel of the Bailadila Projects under adverse and stressful circumstances. The colleagues at Bailadila played an important role in keeping the wheels of the industry running in line with the motto Har ek kaam, Desh ka naam," N Baijendra Kumar, Chairman cum Managing Director of NMDC said in a press release.

He also said that NMDC has ensured that all necessary measures are implemented to meet the challenges posed by the COVID-19 virus and that production is sustained.

He said special arrangements had been made for social distancing,hand-sanitation and sanitization at all its offices and project sites, besides regular health check-ups of personnel at all offices and project so that production is not hampered and can be increased while ensuring effective protection from COVID-19.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
PTI
first published: Jul 8, 2020 08:30 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347